✦ LIBER ✦

Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial

✍ Scribed by David A. Morrow; Yunmei Wang; Kevin Croce; Masashi Sakuma; Marc S. Sabatine; Huiyun Gao; Aruna D. Pradhan; Aileen M. Healy; Jacki Buros; Carolyn H. McCabe; Peter Libby; Christopher P. Cannon; Eugene Braunwald; Daniel I. Simon

Book ID: 116191164
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 300 KB
Volume: 155
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2007.08.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of adiponectin and the risk o

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22)

✍ Sean R. Wilson; Marc S. Sabatine; Stephen D. Wiviott; Kausik K. Ray; James A. De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Improved outcome after acute coronary sy

Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) trial

✍ Jean Rouleau 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 319 KB

On-Statin Cholesteryl Ester Transfer Pro

On-Statin Cholesteryl Ester Transfer Protein Mass and Risk of Recurrent Coronary Events (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)

✍ Amit V. Khera; Megan L. Wolfe; Christopher P. Cannon; Jie Qin; Daniel J. Rader 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Seasonal Variation in Lipids in Patients

Seasonal Variation in Lipids in Patients Following Acute Coronary Syndrome on Fixed Doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)

✍ Patricia Tung; Stephen D. Wiviott; Christopher P. Cannon; Sabina A. Murphy; Caro 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 428 KB

High-dose atorvastatin does not negative

High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients—A Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) analysis

✍ Amir Lotfi; Marc J. Schweiger; Gregory R. Giugliano; Sabina A. Murphy; Christoph 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Effect of statin dose on incidence of at

Effect of statin dose on incidence of atrial fibrillation: Data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) and Aggrastat to Zocor (A to Z) trials

✍ Dalton S. McLean; Shmuel Ravid; Michael Blazing; Bernard Gersh; Amy Shui; Christ 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 242 KB